"Research use only" (RUO) and "not for human consumption" appear on many peptide products. This article explains what those labels mean, and what they don't.
Research compounds versus medicines
A research compound is supplied for laboratory investigation: in vitro experiments, analytical reference standards, method development and similar work. A licensed medicine has been through clinical trials and regulatory assessment, is made under Good Manufacturing Practice, and is approved for specific uses in people. See From lab to licence.
| Research compound | Licensed medicine | |
|---|---|---|
| Intended use | Laboratory research | Treating or preventing disease in people |
| Clinical evidence required | None | Phase I–III trials |
| Manufacturing standard | Varies by supplier | GMP, inspected by regulators |
| Sterility and endotoxin control | Not guaranteed | Required for injectable products |
| Regulator oversight | Not assessed as a medicine | MHRA / EMA / FDA |
An RUO label isn't a safety rating
Even a research compound with excellent HPLC purity hasn't been assessed for safety in people. Purity analysis doesn't show sterility, endotoxin levels or the long-term effects of exposure, and it can't replace clinical evidence.
Presentation matters under UK law
Under the UK's Human Medicines Regulations 2012, a product can be a "medicinal product" because of its function or because of its presentation. If a product is presented as treating or preventing disease in people, or is promoted with dosing or usage guidance for people, regulators can treat it as a medicine whatever its label says. Selling unlicensed medicines to the public is an offence, and the MHRA actively enforces this, including against online sellers.
In practice, an RUO statement only means something when everything else about how a product is marketed and supplied is consistent with genuine research use.
Who genuine research suppliers serve
Legitimate research supply typically serves universities, contract research organisations, biotech and pharmaceutical companies, and analytical laboratories. Documentation is aimed at scientists: COAs, analytical methods and handling information for the laboratory, not for personal use.
Note: this article is general information, not legal advice. Anyone supplying or buying research compounds should take advice from a qualified regulatory professional.
Related articles
- How clinical trials are designed
- How to evaluate peptide research claims
- How laboratories validate analytical methods
Sources and further reading
- The Human Medicines Regulations 2012 (SI 2012/1916). www.legislation.gov.uk/uksi/2012/1916/contents
- Medicines and Healthcare products Regulatory Agency. www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
- MHRA. Clinical trials for medicines: apply for authorisation in the UK. www.gov.uk/guidance/clinical-trials-for-medicines-apply-for-authorisation-in-the-uk